Sarah Norcross – Co-Chair
Sarah Norcross is Director of the Progress Educational Trust (PET), Commissioning Editor of its free weekly email news digest, commentary service and website BioNews
She is also a Member of the Human Fertilisation and Embryology Authority’s National Donation Strategy Group, the Education, Engagement and Training Working Group of the UK Government’s Human Genomics Strategy Group, the National Gamete Donation Trust’s Advisory Council, the Association of Fertility Patient Organisations, Transnational Reproduction’s Research Advisory Group, and the Advisory Group for the project Assessing Child Welfare under the Human Fertilisation and Embryology Act: The New Law at the University of Kent’s Centre for Parenting Culture Studies. She was previously a Member of the National Genetics Education and Development Centre’s Steering Group.
Sarah chaired and coordinated the steering group of clinicians, scientists, patient support groups and medical research charities which fed into policy for the Human Fertilisation and Embryology Act 2008 as it passed through both Houses of Parliament, and she continued this role during the implementation of the Act by the UK Government’s Department of Health and the Human Fertilisation and Embryology Authority.
Susan Seenan – Co-Chair
Susan Seenan is Chief Executive of the patient charity Infertility Network UK – the only national charity in the UK, which supports anyone experiencing fertility issues.
She has first-hand experience of infertility and treatment and understands how difficult it can be to discover that starting a family can be far from simple. She passionately believes that eligibility for NHS fertility treatment should not depend on postcode.
A strong advocate of emotional support and counselling for everyone struggling to conceive, her mission is to change the conversation and get people talking about fertility issues, help promote a better understanding of the options which exist and highlight the extent and impact which infertility can have on people’s lives.
Vicky Whitehead – Secretariat
Vicky joined the FF team in 2014. A Consultant at public affairs firm Decideum Ltd, she heads up the secretariat to FF in conjunction with her colleague Mark Johnson.
She is the primary contact within FF for all things related to data. Having conducted FF’s annual freedom of information request to all CCGs, she has extensive knowledge of the level of variation across the country.
Vicky is also responsible for making contact with policy makers at both a national and local level and for sourcing information for members of the FF team. Prior to joining Decideum, she gained political experience at an NGO in Washington DC and at a think-tank in Westminster. In her free time she is an accomplished hiker and photographer.
Peter is a member of the senior team for public health at Royal Borough of Kingston, where he leads commissioning of sexual and reproductive health on behalf of the LA and the Borough’s CCG. Peter is also the London-wide strategic commissioning lead for SRH, and works as an independent consultant.
Commissioning since 2007, Peter held an eclectic portfolio of services across primary, community and secondary care. Peter has also commissioned specialised services from tertiary centres, such as fertility and HIV care, and headed a national Department of Health programme to create tariffs for assisted conception.
In 2010 Peter became Head of Market Policy for NHS London, the now defunct SHA for the capital, and worked to ensure that the series of values, contracts, and rules; designed to promote patient and taxpayer interests; were instilled and complied with.
Between 2011-2013 Peter worked with the then non-statutory NHS Competition regulator, managing their informal advice service, and was involved in supporting the changing architecture of the NHS, including elements linked to NHS England, CCGs, and regulation.
Peter sat on the GDG for fertility at NICE, and is part of the current Quality Standards Group, as their expert on commissioning.
Tim Child is Medical Director of the Oxford Fertility Unit, Senior Fellow in Reproductive Medicine at the University of Oxford, and Consultant Gynaecologist a the John
Radcliffe Hospital. His undergraduate training wa at the University of Cambridge and London and Postgraduate training in Oxford and Montreal. The Oxford Fertility Unit is one of the UK’s largest IVF centres undertaking over 2000 fresh treatment cycles per year.
Tim was a member of the NICE Guidelines Development Group which resulted in the 2013 NICE Fertility Guidelines.
His research interests focus on novel assisted conception techniques such as oocyte in-vitro maturation (IVM) and also reproductive failure including recurrent miscarriage and implantation failure. He is co-author of the UK’s highest selling undergraduate O&G textbook ‘Obstetrics and Gynaecology’ by Impey and Child, the 5th edition is currently in production.
Barbara Britten is the Divisional Manager for the Reproductive Health & Growth business at Ferring Pharmaceuticals.
Prior to joining the pharmaceutical Industry in 1988, she qualified and worked as an Intensive Care Nurse in London.
Since working in the pharmaceutical industry, her career has been based around either rare or specialist areas of medicine and healthcare.
Jane Denton CBE
Jane Denton is Director of the Multiple Births Foundation (MBF), a charity based at Imperial Healthcare NHS Trust, London, which works with professionals to raise awareness and improve services to meet the specific and special needs of multiple birth families.
Her professional background is nursing and midwifery with a specialist interest in infertility. This led to her work with the MBF as the implications of multiple births arising from infertility treatments began to emerge in the late 1980s. She became Director of the MBF in 1998. She has written and lectured extensively on all aspects of multiple births.
A former member of the Human Fertilisation & Embryology Authority and a founder member of the Royal College of Nursing Fertility Nurses Group Jane has wide experience of the clinical, scientific and ethical challenges presented by the advances in reproductive technologies. She has contributed to substantial change in public and professional attitudes towards multiple births, she is a Fellow of the RCN and was awarded a CBE in 2007 for services to nursing and healthcare.
Dougie Gibb is Head of Fertility UK and Ireland at the pharmaceutical manufacturer, Merck Serono.
A passionate advocate of state funded IVF treatment, Dougie has been a member of the FF team for several years. His knowledge of the sector and ability to spot opportunities and barriers has proven very useful to team.
Royal College of Nursing Representative
FF benefits from the expert input of the Royal College of Nursing policy team and leaders of the RCN Fertility Nursing Forum.
The excellent work of the College needs no further explanation. FF is proud to have them on board and values their input immensely.
Sandra is an Executive Committee Member of the British Infertility Counselling Association (BICA).
BICA is the only professional association for infertility counsellors and counselling in the UK, seeking to promote the highest standards of counselling for those considering or undergoing fertility investigations and treatment.
Given the fundamental importance of counselling as part of the fertility patient pathway, FF is extraordinarily grateful for the support and advice lent to us by Sandra and her team.
Tracey Davey is a Clinical Embryologist at the Nurture Fertility Unit in Nottingham. She received her Biology BSc (Hons) from the University of Nottingham in 2005 before embarking on a position as a trainee Embryologist in Hull. Over the last seven years she has completed the ACE certificate, state registration and gained registration with the HCPC. She has also completed the first part of the RcPath exams becoming an associate member of the Royal College of Pathologists. Tracey is a member of the ACE Executive committee and keen to work closely with issues such as funding and appropriate support for patients affected by infertility.